{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:49:30Z","timestamp":1786992570612,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004956","name":"Bundesministerium f\u00fcr Verkehr, Innovation und Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020617","name":"\u00d6sterreichische Gesellschaft f\u00fcr Gastroenterologie und Hepatologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["FWF P33070"],"award-info":[{"award-number":["FWF P33070"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jhepr.2023.100872","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T06:32:34Z","timestamp":1691044354000},"page":"100872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPAR\u03b3"],"prefix":"10.1016","volume":"5","author":[{"given":"Christoph","family":"Grander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Steinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Claudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Hausmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pjevac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Grabherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Oberhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Grander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Brigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almina","family":"Jukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Schw\u00e4rzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timon E.","family":"Adolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100872_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","article-title":"Global burden of alcoholic liver diseases","volume":"59","author":"Rehm","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100872_bib2","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100872_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100872_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","article-title":"Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis","volume":"34","author":"Lieber","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.jhepr.2023.100872_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","article-title":"Enteric dysbiosis associated with a mouse model of alcoholic liver disease","volume":"53","author":"Yan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100872_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhepr.2023.100872_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100872_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-2275(20)39435-9","article-title":"Effect of ethanol on cholesterol and bile acid metabolism","volume":"13","author":"Lefevre","year":"1972","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhepr.2023.100872_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0024-3205(84)90020-1","article-title":"Depression of biliary glutathione excretion by chronic ethanol feeding in the rat","volume":"34","author":"Vendemiale","year":"1984","journal-title":"Life Sci"},{"key":"10.1016\/j.jhepr.2023.100872_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","article-title":"Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2023.100872_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.redox.2014.08.007","article-title":"Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity","volume":"2","author":"Manley","year":"2014","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhepr.2023.100872_bib13","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1096\/fj.13-231860","article-title":"Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption","volume":"27","author":"Xie","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.jhepr.2023.100872_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.apsb.2014.12.011","article-title":"Role of farnesoid X receptor and bile acids in alcoholic liver disease","volume":"5","author":"Manley","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jhepr.2023.100872_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2023.100872_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.28456","article-title":"Interleukin-1 and inflammasomes in alcoholic liver disease\/acute alcoholic hepatitis and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib17","doi-asserted-by":"crossref","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","article-title":"Pathogenesis of alcoholic liver disease: role of oxidative metabolism","volume":"20","author":"Ceni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100872_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s13340-016-0290-y","article-title":"M2 macrophages in metabolism","volume":"7","author":"Fujisaka","year":"2016","journal-title":"Diabetol Int"},{"key":"10.1016\/j.jhepr.2023.100872_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jhepr.2023.100872_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803037","article-title":"Macrophage polarization and its role in liver disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100872_bib21","article-title":"Telomerase reverse transcriptase acts in a feedback loop with NF-\u03baB pathway to regulate macrophage polarization in alcoholic liver disease","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100872_bib22","article-title":"Effect of modulation of PPAR-\u03b3 activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100872_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPAR\u03b3 activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2023.100872_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","article-title":"Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms","volume":"28","author":"Straus","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jhepr.2023.100872_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.22891","article-title":"Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-\/- mice","volume":"49","author":"Halilbasic","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib26","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/hep.23911","article-title":"Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver","volume":"52","author":"Denk","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.2010.223834","article-title":"Nor-ursodeoxycholic acid reverses hepatocyte-specific NEMO-dependent steatohepatitis","volume":"60","author":"Beraza","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100872_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jhep.2014.11.020","article-title":"24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis","volume":"62","author":"Sombetzki","year":"2015","journal-title":"J\u00a0Hepato"},{"key":"10.1016\/j.jhepr.2023.100872_bib29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib30","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2021.06.036","article-title":"24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation","volume":"75","author":"Zhu","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100872_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100872_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2468-1253(19)30184-0","article-title":"Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial","volume":"4","author":"Traussnigg","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100872_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","article-title":"Tissue processing and hematoxylin and eosin staining","volume":"1180","author":"Feldman","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhepr.2023.100872_bib34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fmicb.2015.00731","article-title":"A\u00a0flexible and economical barcoding approach for highly multiplexed amplicon sequencing of diverse target genes","volume":"6","author":"Herbold","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhepr.2023.100872_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3354\/ame01753","article-title":"Minor revision to V4 region SSU rRNA 806R gene primer greatly increases detection of SAR11 bacterioplankton","volume":"75","author":"Apprill","year":"2015","journal-title":"Aquat Microb Ecol"},{"key":"10.1016\/j.jhepr.2023.100872_bib36","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/cells10071823","article-title":"Cytokine-mediated regulation of ARG1 in macrophages and its impact on the control of Salmonella enterica Serovar Typhimurium infection","volume":"10","author":"Brigo","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jhepr.2023.100872_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gutjnl-2020-321375","article-title":"Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humans","volume":"70","author":"Grander","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100872_bib38","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib39","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100872_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.35946\/arcr.v37.2.09","article-title":"Macrophages and alcohol-related liver inflammation","volume":"37","author":"Ju","year":"2015","journal-title":"Alcohol Res"},{"key":"10.1016\/j.jhepr.2023.100872_bib41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in\u00a0vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhepr.2023.100872_bib42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/hep.24524","article-title":"Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice","volume":"54","author":"Louvet","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib43","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPAR\u03b3 gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhepr.2023.100872_bib44","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1073\/pnas.1031789100","article-title":"PPAR\u03b3 and PPAR\u03b4 negatively regulate specific subsets of lipopolysaccharide and IFN-\u03b3 target genes in macrophages","volume":"100","author":"Welch","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2023.100872_bib45","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1038\/cddis.2012.99","article-title":"PPAR\u03b3 isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation","volume":"3","author":"Strand","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2023.100872_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.livres.2018.12.001","article-title":"Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2","volume":"2","author":"Lee","year":"2018","journal-title":"Liver Res"},{"key":"10.1016\/j.jhepr.2023.100872_bib47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hep.23270","article-title":"Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) extension trial","volume":"51","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.21687","article-title":"Effects of rosiglitazone on the liver histology and mitochondrial function in ob\/ob mice","volume":"46","author":"Garc\u00eda-Ruiz","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib49","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.24558","article-title":"Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial","volume":"54","author":"Torres","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100872_bib50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100872_bib51","article-title":"Suppression of PPAR\u03b3-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis","volume":"6","author":"Yu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2023.100872_bib52","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/acer.13049","article-title":"Hepatic peroxisome proliferator-activated receptor gamma signaling contributes to alcohol-induced hepatic steatosis and inflammation in mice","volume":"40","author":"Zhang","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhepr.2023.100872_bib53","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s00213-020-05540-w","article-title":"PPAR\u03b3 activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study","volume":"237","author":"Schwandt","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jhepr.2023.100872_bib54","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4049\/jimmunol.164.2.1046","article-title":"Activation of peroxisome proliferator-activated receptor \u03b3 does not inhibit IL-6 or TNF-\u0251 responses of macrophages to lipopolysaccharide in\u00a0vitro or in\u00a0vivo","volume":"164","author":"Thieringer","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2023.100872_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yjmcc.2015.04.025","article-title":"Curcumin induces M2 macrophage polarization by secretion IL-4 and\/or IL-13","volume":"85","author":"Gao","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jhepr.2023.100872_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1530-0277.2011.01599.x","article-title":"PPAR\u03b3 ligands regulate NADPH oxidase, eNOS, and barrier function in the lung following chronic alcohol ingestion","volume":"36","author":"Wagner","year":"2012","journal-title":"Alcohol, Clin Exp Res"},{"key":"10.1016\/j.jhepr.2023.100872_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.788558","article-title":"Ursodeoxycholic acid treatment restores gut microbiota and alleviates liver inflammation in non-alcoholic steatohepatitic mouse model","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhepr.2023.100872_bib58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/cam4.1965","article-title":"Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development","volume":"8","author":"Pearson","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jhepr.2023.100872_bib60","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","author":"Llopis","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100872_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chom.2019.11.001","article-title":"Roseburia spp. abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice","volume":"27","author":"Seo","year":"2020","journal-title":"Cell Host Microbe"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:34:57Z","timestamp":1762900497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2589555923002033"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100872","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPAR\u03b3","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100872"}}